Axel Grothey

7PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 10, 2023
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer.

Eric Van Cutsem, Julien Taieb, Rona Yaeger

|May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

Nadine J McCleary, William S Harmsen, Ellana Haakenstad

|Dec 05, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology.

Richard M Goldberg, Richard Adams, Marc Buyse

|Oct 28, 2021
Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients.

Alberto Puccini, Andreas Seeber, Joanne Xiu

|Jul 15, 2021
Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer.

Vanessa Wookey, Axel Grothey

|Apr 21, 2021
Evolution and Current Status of the Multidisciplinary Management of Locally Advanced Rectal Cancer.

Benjamin W Deschner, Noam A VanderWalde, Axel Grothey

Pageof 2